INFU

InfuSystem Holdings, Inc. Healthcare - Medical Devices Investor Relations →

NO
8.4% ABOVE
↓ Approaching Was 11.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $8.38
14-Week RSI 48
Rel. Volume (14w) This week's trading vs. the 14-week average 1.3x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.98

InfuSystem Holdings, Inc. (INFU) closed at $9.09 as of 2026-03-20, trading 8.4% above its 200-week moving average of $8.38. The stock is currently moving closer to the line, down from 11.1% last week. The 14-week RSI sits at 48, indicating neutral momentum.

Trading volume is running at 1.3x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.98 ratio) is neutral — neither side is clearly dominating.

Over the past 903 weeks of data, INFU has crossed below its 200-week moving average 12 times. On average, these episodes lasted 41 weeks. Historically, investors who bought INFU at the start of these episodes saw an average one-year return of +0.4%.

With a market cap of $185 million, INFU is a small-cap stock. The company generates a free cash flow yield of 8.0%, which is notably high. Return on equity stands at 11.5%. The stock trades at 3.2x book value.

Over the past 17.3 years, a hypothetical investment of $100 in INFU would have grown to $379, compared to $991 for the S&P 500. INFU has returned 8.0% annualized vs 14.1% for the index, underperforming the broader market over this period.

Free cash flow has been growing at a 86.1% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: INFU vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After INFU Crosses Below the Line?

Across 12 historical episodes, buying INFU when it crossed below its 200-week moving average produced an average return of -2.0% after 12 months (median -4.0%), compared to +9.9% for the S&P 500 over the same periods. 30% of those episodes were profitable after one year. After 24 months, the average return was +19.5% vs +25.2% for the index.

Each line shows $100 invested at the moment INFU crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

INFU has crossed below its 200-week MA 12 times with an average 1-year return of +0.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Dec 2008Apr 20092145.0%+28.2%+366.2%
Jul 2009Aug 200929.0%-5.4%+251.0%
Aug 2009Oct 20091020.8%N/A+313.2%
Nov 2009Nov 200910.9%-14.6%+239.2%
Nov 2009Jan 20116018.3%+1.6%+263.6%
Feb 2011Feb 201134.7%-31.9%+257.9%
May 2011Dec 201313563.7%-15.7%+248.3%
Oct 2016Mar 20187651.0%-17.0%+259.3%
Apr 2018May 201813.6%+70.2%+256.5%
Mar 2022Aug 202517950.6%-11.0%-12.5%
Dec 2025Jan 202610.2%N/A+8.3%
Jan 2026Feb 202649.9%N/A+10.0%
Average41+0.4%

Frequently Asked Questions

Is INFU below its 200-week moving average?

No. InfuSystem Holdings, Inc. (INFU) is currently 8.4% above its 200-week moving average of $8.38. It would need to fall to $8.38 to cross below the line.

What is INFU's 200-week moving average price?

InfuSystem Holdings, Inc.'s 200-week moving average is $8.38 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when INFU drops below its 200-week moving average?

INFU has crossed below its 200-week moving average 12 times in our data. On average, buying at that moment produced a one-year return of +0.4%. These dips have historically been decent entry points. These episodes lasted 41 weeks on average.

Is INFU a good value right now?

Here's what our data says about INFU as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 48. Free cash flow yield is 8.0%. Return on equity is 11.5%. Price-to-book is 3.2x. This is not a buy or sell recommendation — always do your own research.

How does INFU compare to the S&P 500?

Over the past 17.3 years, $100 invested in INFU would have grown to $379, compared to $991 for the S&P 500. That's 8.0% annualized vs 14.1% for the index. INFU has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20